Diagnosis and treatment of pulmonary cystic hydatidosis.
OBJECTIVE
Hydatidosis is a parasitic infection that is still an important public health problem in Turkey. In the present study, it was planned to review the diagnostic and treatment options.


METHODS
The study was conducted in pediatric pulmonary chest ward of Izmir Chest Diseases and Surgery Training Hospital, a referral tertiary hospital for pulmonary diseases in Western Turkey. Cases were evaluated in clinical presentations, radiological, histopathologic and serological features retrospectively.


RESULTS
Consecutive 17 (11 male and 6 female; mean age 11.29 + 2.44) pediatric cases between 1996 and 2001 were evaluated. Liver involvement was found in 8 (47%) cases. Casoni skin test and IHA test were found positive in 7 (63.6%) and 8 (72.7%) out of 11 cases, respectively. Surgical treatment was performed only in 7 (41.1%) cases as well as surgical plus medical treatment was given in 3 (17.6%) cases. Seven (41.1%) cases were treated just medically.


CONCLUSIONS
Hydatidosis should be considered in the existence of appropriate clinical and radiological findings as a probable diagnosis in all children in our region. Surgery should be the first choice for treatment but, medical therapy was considered as effective for treatment complicated and/or nonsurgical pediatric cases.
Tatar
D
D
Department of Chest Diseases, Diseases of Izmir Chest Diseases and Surgery Training Hospital, Izmir, Turkey.
Senol
G
G
Gunes
E
E
Unsal
S
S
Perim
G
G
D000293:Adolescent; D015766:Albendazole / Q000031:analogs & derivatives / Q000627:therapeutic use; D000923:Anticestodal Agents / Q000627:therapeutic use; D002648:Child; D004445:Echinococcosis, Pulmonary / Q000175:diagnosis* / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D012189:Retrospective Studies; D016896:Treatment Outcome; D014421:Turkey
D000923:Anticestodal Agents; D015766:Albendazole; C027186:albendazole sulfoxide